The Latest Research on Using GLP-1 Drugs to Battle Addiction
GLP-1 drugs in the treatment of addiction was a theme at the 56th annual conference of the American Society of Addiction Medicine (ASAM).
Lilly’s GLP-1 Pill Shines in Phase 3 Trial
GLP-1 drugs in pill form work as well as injectables in Lilly trial.
HDAC5 and the Epigenetics of Addiction
Two new studies explain the role of the epigenetic enzyme, HDAC5, in cocaine addiction and depression.
Mavoglurant Effective Against Cocaine Addiction in Phase 2 Trial
The drug company, Novartis, reports a significant decline in cocaine use with mavoglurant in phase 2 trial.
Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction
Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.
The Impact of GLP-1 Drugs on Reward Pathways
We examine the impact of GLP-1 drugs such as Ozempic on reward pathways and the dopamine system.